区域麻醉随机对照试验结局指标变化:注册与发表比较研究
91.9%的试验在注册版本间至少发生一项实质性结局变更,其中37.8%为高影响修改;最近一次实质性修改发生在主要完成后的占47.1%、发表后的占51.5%,且均未披露。
要点
- 区域麻醉试验注册结局变更普遍,91.9%至少一项实质性变更。
- 高影响修改占37.8%,涉及主要和次要结局。
- 多数最近实质性修改发生在主要完成或发表后且未披露。
核心结论
- 在74项区域麻醉试验中,注册结局字段的早期与最近版本间差异常见,包括主要结局的变更。
- 多数试验最近一次实质性修改发生在主要完成或发表后,且相关论文未明确解释。
研究设计与样本
- 利用ClinicalTrials.gov版本历史比较最早与最近注册记录,按类型、时机和解释影响对变更分类,并评估注册记录和论文中的披露情况。
主要发现
- 74项试验中91.9%在注册版本间至少出现一项实质性结局变更。
- 在有实质性结局修改的试验中,最近一次实质性修改发生在主要完成后的占47.1%,发生在发表后的占51.5%,均未披露。
- 主要和次要结局变更均常见,37.8%的试验存在高影响修改。
- 轻微措辞修改是最常见变更类型,但常伴随测量工具、时间点或分类的更实质性变化。
- 次要结局的增删比主要结局更频繁。
临床怎么用
- 阅读区域麻醉随机对照试验证据时,应核对注册记录与发表论文的结局一致性。
- 关注主要完成或发表后发生的未披露结局修改,警惕高影响变更对结果解释的影响。
局限性
- 研究仅描述注册修改的频率和时机,无法确定修改原因或是否影响报告结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Regional anesthesia (RA) is increasingly used due to its safety and effectiveness in reducing postoperative pain and opioid use. As in other areas of clinical research, transparent and consistent outcome reporting is important for interpreting trial evidence. This study assessed the extent and nature of temporal changes to prespecified outcomes in interventional RA trials registered on ClinicalTrials.gov after the implementation of the Final Rule and the Food and Drug Administration Amendments Act 801. METHODS: We conducted a registry-based cross-sectional analysis of RA trials initiated between January 2017 and December 2024. Eligible trials enrolled adults, were interventional in design, had posted tabular results on ClinicalTrials.gov, and were linked to a peer-reviewed publication. Using ClinicalTrials.gov version histories, we compared the earliest and most recent registry records to identify modifications in outcome definitions, timing and classifications. Changes were categorized by type, timing and interpretive impact. Disclosure of modifications in registry records and publications was assessed. RESULTS: Among 74 eligible trials, 91.9% exhibited at least one substantive outcome change between registry versions. Among trials with substantive outcome modifications, the most recently entered substantive modification occurred after primary completion in 47.1% and after publication in 51.5%, and none were disclosed. Changes to both primary and secondary outcomes were common, with 37.8% of trials exhibiting high-impact modifications. Minor rewording was the most frequent change type, though often accompanied by more substantive shifts in outcome measurement tools, timepoints, or classifications. Secondary outcomes were more frequently added or removed than primary outcomes. DISCUSSION: In this sample of 74 RA trials, differences between the earliest and most recent registered outcome fields were common, including changes involving primary outcomes. For most of these trials, the most recently entered substantive modification occurred after primary completion or publication and was not explicitly explained in the associated publication. These findings describe the frequency and timing of registry modifications but cannot determine why the changes occurred or whether they influenced the reported results.
引用
- McCormick C, Waller D, Langerman R, et al. Assessing the changes in outcome measurements in randomized controlled trials of regional anesthesia interventions: a registry-publication comparison study. Reg Anesth Pain Med. 2026. PMID: 42810771. doi:10.1136/rapm-2026-108295
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。